INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Type | Shares Traded | Price |
|---|---|---|---|---|---|
| Jan 13, 2003 |
SVP, PreclinDevel & Biomol Sci
|
SVP, PreclinDevel & Biomol Sci | Bona fide gift | 250 | $19.65 |
| Dec 15, 2003 |
SVP, PreclinDevel & Biomol Sci
|
SVP, PreclinDevel & Biomol Sci | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 6,977 | -- |
| Dec 15, 2003 |
SVP, PreclinDevel & Biomol Sci
|
SVP, PreclinDevel & Biomol Sci | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 7,692 | -- |
| Dec 15, 2003 |
SVP, PreclinDevel & Biomol Sci
|
SVP, PreclinDevel & Biomol Sci | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 92,308 | -- |
| Jan 09, 2004 |
SVP, PreclinDevel & Biomol Sci
|
SVP, PreclinDevel & Biomol Sci | Open market or private sale of non-derivative or derivative security | 80 | $15.66 |
| Jan 09, 2004 |
SVP, PreclinDevel & Biomol Sci
|
SVP, PreclinDevel & Biomol Sci | Open market or private sale of non-derivative or derivative security | 27 | $15.60 |
| Jan 09, 2004 |
SVP, PreclinDevel & Biomol Sci
|
SVP, PreclinDevel & Biomol Sci | Open market or private sale of non-derivative or derivative security | 80 | $15.57 |
| Jan 09, 2004 |
SVP, PreclinDevel & Biomol Sci
|
SVP, PreclinDevel & Biomol Sci | Open market or private sale of non-derivative or derivative security | 27 | $15.53 |
| Jan 09, 2004 |
SVP, PreclinDevel & Biomol Sci
|
SVP, PreclinDevel & Biomol Sci | Open market or private sale of non-derivative or derivative security | 27 | $15.48 |
| Jan 09, 2004 |
SVP, PreclinDevel & Biomol Sci
|
SVP, PreclinDevel & Biomol Sci | Open market or private sale of non-derivative or derivative security | 27 | $15.47 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.